Meshram P, Maturu VN, Swarnakar R, Deb P, et al. Safety and effectiveness of mepolizumab in adult patients with severe asthma with an eosinophilic phenotype from India: a Phase IV, open-label, single-arm, 24-week study (PRISM). J Asthma 2025 Mar 10:1-15. doi: 10.1080/02770903.2025.2475452.
PMID: 40062664